rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Zydus Lifesciences Ltd.

532321 ZYDUSLIFE Group (A)

05 Jul,15:49
1162.40
25.20 (2.22%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Zydus Lifesciences Ltd.

BUYSELL

113,575 1,137.20 1,166.60 - 1,137.40 1,171.95 - 552.75 116,960.69
NSE | BSE

Zydus Lifesciences Ltd.

ZYDUSLIFE

05 Jul,15:59
1162.45
25.40 (2.23%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Zydus Lifesciences Ltd.

BUYSELL

2,734,011 1137.05 1,166.85 - 1,137.05 1,172.50 - 567.75 3,163,332,747.33

News for Zydus Lifesciences Ltd.

Zydus...
Zydus Lifesciences Gets USFDA Approval for BP Drug
Zydus Lifesciences receives tentative USFDA approval to market generic Azilsartan Medoxomil tablets for treating high blood pressure.
Jul 04, 2024 15:02
Zydus...
Zydus Lifesciences Gets USFDA Nod for Blood Pressure Drug
Zydus Lifesciences receives USFDA approval to market Azilsartan Medoxomil and Chlorthalidone tablets for high blood pressure treatment.
Jun 14, 2024 13:55
Zydus...
Zydus Lifesciences Gets USFDA Nod for Asthma Medication
Zydus Lifesciences has received USFDA approval to market Theophylline extended-release tablets for asthma and COPD. The drug will be manufactured in Ahmedabad SEZ.
May 22, 2024 17:31
Zydus...
Zydus Lifesciences Gets USFDA Nod for Asthma Drug
Zydus Lifesciences receives USFDA approval for its generic Theophylline extended-release tablets for treating asthma and COPD. The drug will be manufactured in Ahmedabad.
May 22, 2024 15:09
Zydus...
Zydus Lifesciences Q4 Profit Surges 4-Fold to Rs 1,182 cr
Zydus Lifesciences' net profit for the fourth quarter ended March 31, 2024, jumped four-fold to Rs 1,182 crore on higher sales. Revenue also rose to Rs 5,534 crore.
May 17, 2024 17:45

More News for Zydus Lifesciences Ltd. »

(Rs. Crore)

Financial Results of Zydus Lifesciences Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,818.708,731.607,981.907,790.406,347.40
Operating profit4,058.702,454.401,918.102,319.101,423.10
Interest390.70278.20134.9070.90233.90
Gross profit4,752.802,724.601,961.902,327.102,038.60
EPS (Rs)34.2115.118.3814.4213.80

See more in Research Center »

News for Pharmaceuticals and health care

Bandhan Bank...
Bandhan Bank Appoints Interim MD & CEO - Ratan Kumar Kesh
Bandhan Bank has appointed Ratan Kumar Kesh as interim MD & CEO, effective July 10. Kesh, previously COO, will serve for three months or until a new CEO is appointed.
Jul 06, 2024 17:34
iVP Semiconductor...
iVP Semiconductor Targets USD 70-100 Million Revenue in 3-4 Years
iVP Semiconductor, a fabless semiconductor startup, aims to achieve USD 70-100 million in revenue within 3-4 years, expanding its presence in power, EV, and IoT sectors. The company has secured USD...
Jul 06, 2024 17:16
Zepto Targets Rs...
Zepto Targets Rs 2.5 Lakh Cr Revenue in 5-10 Years
Zepto CEO Aadit Palicha forecasts Rs 2.5 lakh crore revenue for the quick commerce unicorn in 5-10 years, fueled by strong growth in grocery & household essentials.
Jul 06, 2024 16:07
M3M India...
M3M India Launches Luxury Housing Project in Gurugram
M3M India launches luxury housing project 'M3M Altitude' in Gurugram, expecting Rs 4,000 crore revenue. The 4-acre project offers 350 luxury apartments priced between Rs 10 crore to Rs 30 crore.
Jul 06, 2024 15:29
BigBloc...
BigBloc Construction to Consider Bonus Share Issue - July 19
BigBloc Construction Ltd will consider a bonus share issue on July 19. The company also plans to launch an SME IPO or preferential issue for its subsidiary. Learn more about this development.
Jul 06, 2024 14:46

More News »

Top News

Bandhan Bank...
Bandhan Bank Appoints Interim MD & CEO - Ratan Kumar Kesh
Bandhan Bank has appointed Ratan Kumar Kesh as interim MD & CEO, effective July 10. Kesh, previously COO, will serve for three months or until a new CEO is appointed.
Jul 06, 2024 17:34
iVP Semiconductor...
iVP Semiconductor Targets USD 70-100 Million Revenue in 3-4 Years
iVP Semiconductor, a fabless semiconductor startup, aims to achieve USD 70-100 million in revenue within 3-4 years, expanding its presence in power, EV, and IoT sectors. The company has secured USD...
Jul 06, 2024 17:16
Areca & Coconut Prices in Mangaluru - July 6
Check the latest areca and coconut prices in Mangaluru for Saturday, July 6th. Get details on old and new supari, koka, and coconut quality prices.
Jul 06, 2024 17:15
Zepto Targets Rs...
Zepto Targets Rs 2.5 Lakh Cr Revenue in 5-10 Years
Zepto CEO Aadit Palicha forecasts Rs 2.5 lakh crore revenue for the quick commerce unicorn in 5-10 years, fueled by strong growth in grocery & household essentials.
Jul 06, 2024 16:07
M3M India...
M3M India Launches Luxury Housing Project in Gurugram
M3M India launches luxury housing project 'M3M Altitude' in Gurugram, expecting Rs 4,000 crore revenue. The 4-acre project offers 350 luxury apartments priced between Rs 10 crore to Rs 30 crore.
Jul 06, 2024 15:29

More Top News »

Report Card

PE Ratios
33.98
EPS (Rs.)
34.21
Sales (Rs. Cr)
3,332.40
Face Value (Rs.)
1
Net Profit Margin (%)
17.51
Last Bonus
1:2
Last Dividend(%)
300
Return on Average Equity
11.21

Compare 'Zydus Lifesciences Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,557.95
  • Compare
  • Divi's Laboratories Ltd.
  • 4,542.55
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,482.50
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,871.05
  • Compare
  • Max Healthcare Institute Ltd.
  • 917.55
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,232.50
  • Compare
  • Alkem Laboratories Ltd.
  • 4,977.35
  • Compare

Zydus Lifesciences Ltd. performance snapshot

If you had invested Rs.  in Zydus Lifesciences Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add Zydus Lifesciences Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Zydus Lifesciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close